Skip to content
  • Sunday, 26 July 2026
  • 2:59 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • ETH Zurich Researchers Identify Breakthrough Compound 10 as a Potential New Frontier in Alzheimer’s Disease Treatment and Neuroprotection
Neuroscience & Brain Research

ETH Zurich Researchers Identify Breakthrough Compound 10 as a Potential New Frontier in Alzheimer’s Disease Treatment and Neuroprotection

Rifan Muazin Jun 18, 2026 0

A multidisciplinary research team at ETH Zurich has announced the discovery of a novel experimental substance, currently designated as Compound…

Read More
Neuroscience & Brain Research

Indiana University Researchers Identify IDOL Enzyme as Novel Therapeutic Target for Alzheimer’s Disease Treatment and Neuroprotection

Rifan Muazin May 21, 2026 0

The global fight against Alzheimer’s disease has reached a critical juncture as researchers at the Indiana University School of Medicine…

Read More
Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.Evogene and ELEO Forge Strategic Alliance to Pioneer Next-Generation Oral PCSK9 Inhibitors for Cardiovascular DiseaseVitestro Secures $70 Million in Oversubscribed Series B to Accelerate Autonomous Phlebotomy Development and Global CommercializationAdvancing Cancer Research and Life Sciences: Insights from AACR and North American Innovation Landscape
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ